MedAlliance
MedAlliance is a privately-held Swiss medical technology company founded in 2008 and headquartered in Nyon. Backed by CITIC Capital and Trustar Capital, the firm pursues growth through acquisitions in the medtech sector.
- Company typePrivate
- Founded2008
- HeadquartersNyon, Switzerland
- Headcount51–100
- GTM typeB2B
- OfferingHardware or Manufacturing
What MedAlliance does
MedAlliance is a privately-held medical technology company headquartered in Nyon, Switzerland. Founded in 2008, the company operates as a for-profit private enterprise with 51-100 employees. The company is positioned in the European medical technology sector, with its Swiss domicile providing access to established medtech infrastructure and CE marking regulatory pathways. Specific product portfolio, pipeline, and indication details are not disclosed in the available source material.
The company has attracted significant institutional capital, raising $50 million in a Series 4 funding round on March 17, 2021, led by CITIC Capital Holdings with participation from Trustar Capital. This capital raise reflects institutional confidence in MedAlliance's commercial prospects. The company has also pursued inorganic growth, completing the acquisition of MDK Medical on February 3, 2022, for an undisclosed amount, suggesting a strategic consolidation or capability-expansion play within the medtech sector. The combination of institutional capital, M&A activity, and an established C-suite indicates the company is in an active scaling phase.
MedAlliance is led by Jeffrey B. Jump, who serves as Chairman and CEO, with Joseph Shultz as Chief Technology Officer and Scott Addonizio as Chief Operating Officer. The company operates as a private entity without disclosed public listing plans. The absence of detailed product, customer, revenue, and competitive positioning data in the source material limits deeper commercial assessment, but the available signals (institutional backing, M&A activity, mid-sized headcount) suggest an established mid-market medtech firm pursuing growth.
MedAlliance firmographics
Firmographics- Name
- MedAlliance
- Legal name
- Knowledge
- Website
- https://medalliance.com
- Company type
- Private
- Founded year
- 2008
- Operating status
- Operating
- Headcount range
- 51–100 employees
- Short description
- MedAlliance is a privately-held Swiss medical technology company founded in 2008 and headquartered in Nyon. Backed by CITIC Capital and Trustar Capital, the firm pursues growth through acquisitions in the medtech sector.
- Ownership category
- akta.pro rank
Where MedAlliance is headquartered
LocationHeadquarters
- HQ city
- Nyon
- HQ country
- Switzerland
- HQ region
- Europe
Offices1 record
Markets served
MedAlliance business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Technology or R&D, Operations, Personnel, Marketing or Sales, Supply Chain
Revenue model
- Professional Services and Consulting: Knowledge operates as an intelligent processes consultancy, generating revenue through custom software development, AI integration projects, data analytics consulting, and structural consulting services. Projects are delivered using iterative sprint methodologies with functional prototypes, suggesting project-based engagement rather than recurring subscriptions.
Go-to-market motion1 record
Distribution channels1 record
Marketing channels3 records
MedAlliance product offering
Product offeringCore offering
MedAlliance is a privately-owned medical technology company founded in 2008 and headquartered in Nyon, Switzerland, operating with 51–100 employees. Beyond its classification as a medical technology business and its growth-stage investor backing, the supplied source material does not detail specific commercial products, services, or therapeutic areas; the only explicitly disclosed business events are a $50 million financing round (March 2021, led by CITIC Capital Holdings with Trustar Capital) and the acquisition of MDK Medical (February 2022).
Product overview
Knowledge Intelligent Processes (Knowledge) operates as a technology consulting firm offering a portfolio of digital solutions centered around web/mobile development, AI integration, data analytics, and structural consulting services. The core offerings include custom web and mobile application development, AI-powered automation solutions (bots, assistants, recommendations), data analysis and visualization (dashboards, demand forecasting), and structural business consulting. The product portfolio is delivered through an agile methodology using systems thinking, with iterative sprints producing functional prototypes that evolve through real-world testing and feedback. The company serves multiple sectors including healthcare (pre-hospital care, medical records digitization), transportation (route optimization), and general business operations.
Differentiator
Problem solved
Functional benefit
Products and services
- Medical devices and related medical technology products (specific product names not disclosed in source)
Quantifiable outcome
- Reduction in registration errors and improved response times through digitalized pre-hospital care operations
- +6 more outcomes
Companies that use MedAlliance
Customer profileNamed customers8 records
Segments3 records
Ideal customer profiles1 record
MedAlliance technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
AI capability8 records
Feature5 records
MedAlliance partnerships and signals
Strategic signalScale indicators1 record
Recent moves3 records
Expansion highlights3 records
MedAlliance competitors and assessment
Company assessmentDirect peers
- Boston Scientific: Boston Scientific is a global interventional cardiology and peripheral vascular incumbent with the Ranger and Eluvia drug-coated/drug-eluting platforms, directly competing with MedAlliance in the DCB category across coronary and peripheral indications.
- Medtronic: Medtronic markets the IN.PACT Admiral and IN.PACT AV drug-coated balloons for peripheral and AV access indications, making it a directly comparable DCB competitor with global commercial reach.
- BD (Bard): BD's Peripheral Intervention business sells the Lutonix drug-coated balloon for superficial femoral artery and below-the-knee lesions, directly overlapping MedAlliance's peripheral vascular indication footprint.
- Abbott: Abbott competes in the interventional vascular space with bioresorbable scaffolds, drug-eluting stents, and balloon technologies, providing overlapping solutions for the same physician call points as MedAlliance.
- B. Braun: B. Braun's Aesculap division markets the SeQuent Please neo paclitaxel-coated balloon, a directly competitive coronary and peripheral DCB that competes for the same procedural share as MedAlliance's sirolimus platform.
- Terumo: Terumo's interventional systems division sells drug-eluting balloons and stents for coronary and peripheral applications, competing head-to-head with MedAlliance in Asian and European markets.
Emerging players
- Concept Medical: Concept Medical is an emerging DCB specialist with the MagicTouch sirolimus-coated balloon, competing directly with MedAlliance's sirolimus technology in coronary and peripheral vascular indications.
- SurModics: SurModics is a smaller specialty player focused on drug-delivery coating technology used in DCBs and other vascular devices, providing adjacent technology competition to MedAlliance's proprietary sirolimus coating.
- Shockwave Medical: Shockwave Medical pioneered intravascular lithotripsy as an alternative to DCB and stenting for calcified lesions, representing an emerging adjacent technology competing for the same vascular interventional procedures.
Broad incumbents
- Cordis: Cordis is a global cardiovascular interventional device incumbent with a broad portfolio across coronary and peripheral vascular, positioning it as a strategic acquirer and broad competitor in the same procedural categories as MedAlliance.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat2 records
Key highlights6 records
Customer concentration
MedAlliance social profiles
Digital presenceMedAlliance financial estimates
Financial estimateRevenue estimate
Valuation estimate
MedAlliance leadership team
Management profileNumber of profiles
Profiles3 records
MedAlliance funding detail
Funding detailFunding overview
Funding rounds1 record
Investors2 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
MedAlliance M&A and investment
M&A and investmentM&A1 record
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about MedAlliance
What does MedAlliance do?
MedAlliance is a privately-owned medical technology company founded in 2008 and headquartered in Nyon, Switzerland, operating with 51–100 employees. Beyond its classification as a medical technology business and its growth-stage investor backing, the supplied source material does not detail specific commercial products, services, or therapeutic areas; the only explicitly disclosed business events are a $50 million financing round (March 2021, led by CITIC Capital Holdings with Trustar Capital) and the acquisition of MDK Medical (February 2022).
Is MedAlliance a public or private company?
MedAlliance is a private company. It is classified as venture growth investor backed and is currently operating.
When was MedAlliance founded?
MedAlliance was founded in 2008. It employs 51 to 100 people.
Where is MedAlliance based?
MedAlliance is headquartered in Nyon, Switzerland, in the Europe region.
How does MedAlliance make money?
One revenue line is on record: professional Services and Consulting.
Who are MedAlliance's main competitors?
Direct peers on record are Boston Scientific, Medtronic, BD (Bard), Abbott, B. Braun and Terumo. Emerging players are Concept Medical, SurModics and Shockwave Medical. Cordis is listed as a broad incumbent.
Does MedAlliance have an API?
No public API is recorded for MedAlliance.